An Israeli company has developed breakthrough technology​ that can predict the body’s response to different cancer treatments, improving efficacy and reducing side effects.

Israeli company OncoHost has developed first-of-its-kind artificial intelligence (AI) technology that predicts a patient’s reaction to different cancer treatments.

With OncoHost, doctors make better therapeutic choices with less side effects.

If this breakthrough technology wasn’t amazing enough, it also can help advance the development of new treatments.